Company intelligence / Profile preview

Carebot

Ownership: Private
Development stage: Commercial

Overview

Carebot has developed an AI-powered tool that assists radiologists and clinicians in interpreting chest X-rays with up to 99% sensitivity. The system is being piloted in hospitals and aims to accelerate diagnosis time by up to 33%, improve accuracy of findings, and reduce routine workload for doctors. The technology is currently focused on chest X-rays but is being expanded toward other modalities like CT and MRI. Early clinical deployments are ongoing; commercial rollout is anticipated following regulatory certification

Therapeutic areas: PulmonologyOther
Modalities: DeviceNon-pharmacological therapyArtificial intelligence software (for diagnostic support)
Industry: Medical Imaging

Partnerships

Pilulka Lab accelerator program

Beyond the preview

Go deeper on Carebot.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carebot.

Explore the full profile